Is a complete BDTX research report available?

No complete published report is available for Black Diamond Therapeutics, Inc. (BDTX) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Black Diamond Therapeutics, Inc. (BDTX)

NASDAQ: BDTX · USD

$1.72

+0.05 (+3.3%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first BDTX analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	98.3M
Net income (ttm)	-43.2M
EPS (ttm)	-$0.76
Shares out	57.3M
Volume	536,441
Beta	3.25
Price target	$9.86	+474.9%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -43.2M
EPS (ttm): -$0.76
Market cap: 98.3M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All BDTX indicators

Market & fundamental data

Available fields

188

Groups with data

Currency

USD

Showing 188 of 188 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001701541
Company name	Black Diamond Therapeutics, Inc.
Country	United States
Country code	US
Cusip	09203E105
Employees	21
Employees Change	-3%
Employees Change Percent	-12.5
Enterprise value	$-2.1M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2020-01-30
Isin	US09203E1055
Last refreshed	2026-07-31
Market cap	$98.3M
Market cap category	Micro-Cap
Price	$1.72
Price currency	USD
Sector	Healthcare
Sector PE	45.64
Sector PE Fwd	24.21
Sic	2836
Symbol	BDTX
Website	https://www.blackdiamondtherapeutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-43.97%
FCF yield	-34.63%
P/B ratio	0.94x
PS Forward	17.69x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-43.2M
Net Income Growth Years	4%
Profit Per Employee	$-2.1M
Profitable Years	1
ROA	-18.57
Roa5y	-23.24
ROCE	-44.99
ROE	-35.16
Roe5y	-45.22
ROIC	-20.12

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-38.33%
Cagr3y	-21.9%
Cagr5y	-28.77%
EPS Growth Years	4
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$132.9M
Cash	$118.3M
Current Assets	$123M
Current Liabilities	$14.5M
Debt	$17.9M
Debt Equity	$0.17
Equity	$104.3M
Liabilities	$28.6M
Long Term Assets	$10M
Long Term Liabilities	$14.1M
Net Cash	$100.4M
Net Cash By Market Cap	$102
Net Cash Growth	-23.27%
Net Debt Equity	$-0.96
Tangible Book Value	$104.3M
Tangible Book Value Per Share	$1.82
WACC	18.72

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	8.46
Net Working Capital	$-6M
Quick ratio	8.14
Working Capital	$108.4M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.91%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-38.31%
200-day SMA	2.65
3Y total return	-52.36%
50-day SMA	1.98
50-day SMA vs 200-day SMA	50under200
5Y total return	-81.66%
All Time High	46.25
All Time High Change	-96.29%
All Time High Date	2020-06-03
All Time Low	1.18
All Time Low Change	45.34%
All Time Low Date	2022-10-17
ATR	0.12
Beta	3.25
Beta1y	2.38
Beta2y	2.38
Ch YTD	-29.42
High	1.72
High52	4.94
High52 Date	2025-11-12
High52ch	-65.28%
Low	1.65
Low52	1.6
Low52 Date	2026-06-23
Low52ch	7.19%
Ma50ch	-13.25%
Premarket Change Percent	1.81
Premarket Price	$1.69
Price vs 200-day SMA	-35.36%
RSI	41.45
RSI Monthly	39.5
RSI Weekly	38.11
Sharpe ratio	-0.16x
Sortino ratio	-0.15
Total Return	-0.91%
Tr YTD	-29.42
Tr1m	-2%
Tr1w	-6.79%
Tr3m	-33.27%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	9
Analyst Count Top	5
Analyst Price Target Top	$10.25
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.2
Earnings Revenue Estimate	30,000,000x
Operating Income	$-45.9M
Price target	$9.86
Price Target Change	$475
Price Target Change Top	$498

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	52,449,676%
Float Percent	91.53%
Shares Insiders	0.7%
Shares Institutions	53.46%
Shares Out	57,301,774
Shares Qo Q	0.25%
Shares Yo Y	0.91%
Short Float	11.16%
Short Ratio	2.81
Short Shares	10.21

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-40.4M
Adjusted OCF	-40,403,000
Average Volume	946,348.55x
Bv Per Share	1.82
Ch1m	-2
Ch1w	-6.79
Ch1y	-38.31
Ch3m	-33.27
Ch3y	-52.36
Ch5y	-81.66
Ch6m	-34.79
Change	3.31%
Change From Open	2.08
Close	1.66
Days Gap	1.2
Depreciation Amortization	265,000
Dollar Volume	919,996.3
Earnings Date	2026-08-06
Earnings Time	bmo
EBIT	$-53.3M
EBITDA	$-54M
EPS	$-0.76
F Score	1
FCF	$-34M
FCF EV Yield	1,617.72x
FCF Per Share	$-0.59
Financing CF	-363,000
Fiscal Year End	December
Founded	2,014
Investing CF	-33,952,000
Ipr	-90.97
Iprfo	-94.8
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-16
Ma150	2.34
Ma150ch	-26.65%
Ma20	1.85
Ma20ch	-7.05%
Net CF	-68,343,000
Next Earnings Date	2026-08-10
Open	1.68
Optionable	Yes
Position In Range	92.86
Post Close	1.72
Postmarket Change Percent	0.29
Postmarket Price	$1.72
Ppne	9,095,000
Pre Close	1.66
Price Date	2026-07-30
Ptbv Ratio	0.94
Relative Volume	0.57x
Share Based Comp	6,375,000
Tr6m	-34.79%
Us State	Massachusetts
Volume	536,441
Z Score	-1.93

Black Diamond Therapeutics, Inc. (BDTX)

Coverage state: Market snapshot only — no published research

Generate the first BDTX analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · BDTX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BDTX indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on BDTX

Frequently asked questions